Interactions Between Antibody-Coated Iron Micro-Particles and Leukemic Cells as seen by Electron Microscopy

C J Bieva1, R Mosselmans2, F V Brugghen1

  • 1a Dept. Hématologie, Service de Médicine Interne et Laboratoire d'Investigation Clinique H. Tagnon, Brussels, Belgium.

Leukemia & Lymphoma
|July 27, 2016
PubMed

Insights

Monoclonal antibody-coated microparticles target leukemic cells. CD10 antibody-coated particles penetrate cells at 37°C, offering potential for targeted drug delivery in cancer therapy.

Area of Science:

  • Biomedical Engineering
  • Cell Biology
  • Immunology

Background:

  • Monoclonal antibodies (MoAbs) conjugated to ferromagnetic microparticles are used for purging leukemic cells from autografts.
  • Previous studies have reported the properties of this reagent for autologous bone marrow transplantation (ABMT).

Purpose of the Study:

  • To visualize the interaction between MoAb-coated ferromagnetic microparticles and leukemic cells using electron microscopy.
  • To investigate the effect of temperature and incubation time on particle-cell interactions.

Main Methods:

  • Transmission electron microscopy was employed to observe interactions.
  • A CD10+ NALM6- cell suspension was incubated with CD10 or CD8 MoAb-conjugated particles.
  • Incubation occurred over a time course (0-90 min) at 4°C and 37°C.

Main Results:

  • CD10 MoAb-particles complexed with the cell surface at 4°C.
  • At 37°C, CD10 MoAb-particles readily penetrated leukemic cells.
  • CD8 MoAb-particles showed no interaction with cells at either temperature or duration.

Conclusions:

  • Temperature-dependent cellular uptake of CD10 MoAb-conjugated microparticles was demonstrated.
  • This suggests a potential for site-specific drug delivery by internalizing pharmaceutical agents linked to magnetic carriers.
  • The CD8 MoAb-particle interaction was negligible, highlighting the specificity of the CD10-mediated uptake.